EUVIMEDEUVIMED entdecken
Open Access

Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy

Ping Wang, Yan-Han Chen, Ze-Tao Zhan, Jun-Xiang Zeng, Yu Chen, Yuan Lin, Tao Chen, Wei-Jie Zhou

Oncology Research · 2026

DOI: 10.32604/or.2025.071902 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Oncology Research, 2026. Verfasst von Ping Wang und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medic…. Hauptthemen laut MEDLINE: Thimerosal, Immunotherapy, Programmed Cell Death 1 Receptor, Colorectal Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ThimerosalImmunotherapyProgrammed Cell Death 1 ReceptorColorectal NeoplasmsImmune Checkpoint InhibitorsAnimalsMiceHumansCell ProliferationCell Line, TumorApoptosisCD8-Positive T-LymphocytesMice, Inbred C57BLDisease ProgressionMale

Stichwörter der Autor:innen

Janus kinase 1/signal transducer and activator of transcription 3Thimerosalcolorectal cancerimmunotherapymelanomamercury ionsprogrammed cell death protein 1repurposed drug

Substanzen

ThimerosalProgrammed Cell Death 1 ReceptorPDCD1 protein, humanImmune Checkpoint Inhibitors

Autor:innen und Institutionen

  • Department of General Surgery, Guangdong Provincial Key Laboratory of Precision Medicine for Gastrointestinal Tumor, Nanfang Hospital, Southern Medical University, Guangzhou, 510515, China.
  • State Key Laboratory of Organ Failure Research, Cancer Research Institute, School of Basic Medical Sciences, Southern Medical University, Guangzhou, 510515, China.
  • Department of Gastroenterology, The Seventh Affiliated Hospital of Southern Medical University, Foshan, 528244, China.
  • The Second School of Clinical Medicine, Southern Medical University, Guangzhou, 510280, China.
  • Department of Gastrointestinal and Hernia Surgery, Ganzhou Hospital-Nanfang Hospital, Southern Medical University, Ganzhou, 341000, China.

Zitieren

APA

Wang, P., Chen, Y. H., Zhan, Z. T., Zeng, J. X., Chen, Y., Lin, Y., Chen, T., & Zhou, W. J. (2026). Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy. Oncology Research. https://doi.org/10.32604/or.2025.071902

Vancouver

Wang P, Chen YH, Zhan ZT, Zeng JX, Chen Y, Lin Y, et al. Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy. Oncology Research. 2026. doi:10.32604/or.2025.071902

BibTeX
@article{Wang2026,
  author = {Wang, Ping and Chen, Yan-Han and Zhan, Ze-Tao and Zeng, Jun-Xiang and Chen, Yu and Lin, Yuan and Chen, Tao and Zhou, Wei-Jie},
  title = {Thimerosal Inhibits Tumor Malignant Progression through Direct Action and Enhancing the Efficacy of PD-1-Based Immunotherapy},
  journal = {Oncology Research},
  year = {2026},
  doi = {10.32604/or.2025.071902}
}
Kostenlos starten →